Evidence map›Paper›PMID 41603648›Full record

ArticleBriefings in bioinformatics2026

Ab initio detection of multiple epitranscriptomic modifications from Oxford nanopore technology direct RNA sequencing data.

Adriano Fonzino, Bruno Fosso, Grazia Visci, Carmela Gissi, Graziano Pesole, Ernesto Picardi

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Epitranscriptomic Analysis of A-to-I RNA Editing and mInternational journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adriano FonzinoDepartment of Biosciences, Biotechnology, and Environment, University of Bari Aldo Moro, Via Orabona 4, 70125, Bari, Italy.
Bruno FossoDepartment of Biosciences, Biotechnology, and Environment, University of Bari Aldo Moro, Via Orabona 4, 70125, Bari, Italy.ORCID 0000-0003-2324-086X
Grazia VisciDepartment of Biosciences, Biotechnology, and Environment, University of Bari Aldo Moro, Via Orabona 4, 70125, Bari, Italy.
Carmela GissiDepartment of Biosciences, Biotechnology, and Environment, University of Bari Aldo Moro, Via Orabona 4, 70125, Bari, Italy.ORCID 0000-0002-2269-079X
Graziano PesoleDepartment of Biosciences, Biotechnology, and Environment, University of Bari Aldo Moro, Via Orabona 4, 70125, Bari, Italy.ORCID 0000-0003-3663-0859
Ernesto PicardiDepartment of Biosciences, Biotechnology, and Environment, University of Bari Aldo Moro, Via Orabona 4, 70125, Bari, Italy.ORCID 0000-0002-6549-0114

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Charting the eukaryotic epitranscriptome by direct RNA sequencing is promising but still very challenging, as current bioinformatics tools are based on modification-unaware software and require multiple modification-specific learning steps. Here, we introduce NanoSpeech, a modification-aware basecaller for the ab initio simultaneous detection of multiple modified bases using a transformer model, and NanoListener, which implements a simulated randomers strategy for robust training datasets and a new generation of ONT basecallers. NanoListener and NanoSpeech are independent of the specific ONT chemistry. Once a training dataset has been created, a single model with an expanded vocabulary can accurately basecall both unmodified and modified bases.

Indexed as

Nanopore SequencingRNASequence Analysis, RNASoftwareComputational BiologyEpitranscriptomeEpitranscriptomicsHumansRNAdirect RNA sequencingepitranscriptomicsONT RNA basecallingRNA editingRNA modifications

Identifiers

PMID41603648
PMCPMC12848937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.